Drug · DIN 02338327
ADCIRCA
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since May 29, 2026; first marketed January 19, 2010.
- Drug Identification Number (DIN)
- 02338327
- Company (DIN owner)
- Eli Lilly Canada IncToronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Tadalafil G04BE08
- Class
- Human
- Record last updated
- June 15, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| TADALAFIL | 20 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- November 25, 2009: NOC 10802New Drug Submission (NDS)